Health care remains one of the best-performing sectors year-to-date, down just 9.62%, but it’s a broad sector that includes a lot of subindustries. As a result, performance can vary widely depending on the industry and market-cap segment.
Today we head from the $16 billion pharmaceuticals company Catalent, which reported better-than-expected earnings, but revenues fell short of expectations. Additionally, its revenue and full-year outlook came in below estimates.
Overall, investors did not appear thrilled with what they heard from the company, sending the stock down 7.44% towards its YTD lows. 📉